Cover Image

PAPERBACK
$54.00



View/Hide Left Panel

Appendix F.5

Scientific Forum for Biomedical and Behavioral Research

Results are presented below of a November 2011 meeting in Moscow, organized under the auspices of the Foundation for the National Institutes of Health, to foster U.S.-Russia scientist-to-scientist collaboration and to organize training courses for Russian scientists.

A: THEMATIC AREAS OF INTEREST

Active and healthy lifestyles

Brain sciences

Cancer

Human development

Cardiovascular disease

Infectious and rare disease

Clinical and translational research training

B: PARTICIPATING COMPANIES

Eli Lilly, Amway, Amgen, Abbott, Coca Cola, Johnson and Johnson, Genzyme, Pfizer, Pepsi Cola, Bristol Myers Squibb, Bach Pharma, Celgene, Merck, Genetic Alliance, Novartis, ChemDiv, and ChemRar.



The National Academies | 500 Fifth St. N.W. | Washington, D.C. 20001
Copyright © National Academy of Sciences. All rights reserved.
Terms of Use and Privacy Statement



Below are the first 10 and last 10 pages of uncorrected machine-read text (when available) of this chapter, followed by the top 30 algorithmically extracted key phrases from the chapter as a whole.
Intended to provide our own search engines and external engines with highly rich, chapter-representative searchable text on the opening pages of each chapter. Because it is UNCORRECTED material, please consider the following text as a useful but insufficient proxy for the authoritative book pages.

Do not use for reproduction, copying, pasting, or reading; exclusively for search engines.

OCR for page 239
Appendix F.5 Scientific Forum for Biomedical and Behavioral Research Results are presented below of a November 2011 meeting in Moscow, orga- nized under the auspices of the Foundation for the National Institutes of Health, to foster U.S.-Russia scientist-to-scientist collaboration and to organize training courses for Russian scientists. A: THEMATIC AREAS OF INTEREST Active and healthy lifestyles Brain sciences Cancer Human development Cardiovascular disease Infectious and rare disease Clinical and translational research training B: PARTICIPATING COMPANIES Eli Lilly, Amway, Amgen, Abbott, Coca Cola, Johnson and Johnson, Gen- zyme, Pfizer, Pepsi Cola, Bristol Myers Squibb, Bach Pharma, Celgene, Merck, Genetic Alliance, Novartis, ChemDiv, and ChemRar. 239

OCR for page 239
240 APPENDIX F.5 C: ONGOING AND PROPOSED PROJECTS 1: Conjugated Vaccine against Pseudomonas aeruginosa • Interested Russian organizations: Zelinsky Institute of Organic Chemis- try, High Chemical College, Mechnikov Institute of Vaccines and Sera, Federal State Unitary Company Microgen Scientific Industrial Company for Immunobio- logical Medicines • Interested U.S. organization: Harvard Medical School 2: Simultaneous Multitarget Therapy of Tumors • Interested Russian organizations: Institute of Chemical Biology and Fundamental Medicine, Vavilov Institute of General Genetics, Institute of Gene Biology, Institute of Molecular Genetics, Shemyakin-Ovchinnikov Institute of Bioorganic Chemistry, Blokhin Cancer Center 3: Modular Nanotransporters and Chemically Synthesized Modules • Interested Russian organization: Institute of Gene Biology • Interested U.S. organization: Duke University 4: HIV-Tuberculosis Diagnosis and Drug Discovery • Interested Russian organizations: Ivanovsky Institute of Virology, Cen- tral Research Institute of Tuberculosis, Central Research Institute of Epidemi- ology, Vavilov Institute of General Genetics; Institute of Organic Synthesis; Institute of Organic Chemistry • Interested U.S. partners: Ely Lilly, Infectious Disease Research Institute of Seattle 5: Medical Proteomics in the Context of Bioinformatics Strategy DELSA (Data-Enabled Life Sciences) • Interested Russian organization: Institute of Biomedical Chemistry • Interested U.S. organizations: Houston Children’s Hospital, Fred Hutchinson Cancer Research Center, Center for Computational Medicine and Biology at the University of Michigan, Department of Chemistry and Chemical Biology at Northeastern University

OCR for page 239
APPENDIX F.5 241 6: Human Microbiome: Metagenomics, New Biomarkers of Disease, Translational Research in Personalized Medicine • Interested Russian organizations: Vavilov Institute of General Genet- ics, Institute of Chemical Biology and Fundamental Medicine (Novosibirsk), Institute of Biomedical Problems, Moscow State University, Research Institute of Physical-Chemical Medicine • Interested U.S. organizations: Institute for Genome Sciences, University of Maryland School of Medicine, George Mason University 7: Preclinical Development and Preventive Treatment of Neurodegenerative Disease • Interested Russian organizations: Institute of Developmental Biology, Institute of Molecular Genetics, Institute of Bioorganic Chemistry, Institute of Physiologically Active Substances, Institute of Evolutionary Physiology and Biochemistry (St. Petersburg), Institute of Normal Physiology, Zakusov Institute of Pharmacology, Moscow State Medical University • Interested U.S. organizations: National Institute of Neurological Disor- ders and Stroke, Washington University, Institute for Degenerative Disorders D: PROPOSED FORUM MEETINGS 2012: Rare Diseases and Drug Development 2013: Brain Sciences 2014: Infectious Diseases and Cancer 2015: Healthy Lifestyles and Cardiovascular Diseases E. POTENTIAL FUNDING ORGANIZATIONS IN RUSSIA Ministry of Education and Science, Ministry of Industry and Trade, Skolkovo Foundation SOURCE: Ann Ashby, NIH Foundation (Ann.Ashby@NIH.gov).

OCR for page 239